Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Journal of Empirical Research on Human Research Ethics : JERHRE
|
November 29, 2017
Reply to Commentary: "Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?"
Karine Dubé, Laurie Sylla, Lynda Dee
American Journal of Public Health
|
December 15, 2012
A pilot study of the impact of housing first-supported housing for intensive users of medical hospitalization and sobering services
Debra Srebnik, Tara Connor, Laurie Sylla
Psychiatric Services (Washington, D.C.)
|
February 3, 2015
A pilot study of the diabetes prevention program on weight loss for adults at community mental health centers
Debra Srebnik, Lydia A Chwastiak, Joan Russo, et al.
The International Journal on Drug Policy
|
August 11, 2007
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications
R Douglas Bruce, Sergey Dvoryak, Laurie Sylla, et al.
HIV Research & Clinical Practice
|
July 29, 2022
Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States
Laurie Sylla, Hursch Patel, Michael Louella, et al.
The Journal of Behavioral Health Services & Research
|
August 13, 2016
Creating a Regional Model to Coordinate and Prioritize Access to Permanent Supportive Housing
Laurie Sylla, René Franzen, Debra Srebnik, et al.
The International Journal on Drug Policy
|
August 11, 2007
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services
Laurie Sylla, R Douglas Bruce, Adeeba Kamarulzaman, et al.
The American Journal of Drug and Alcohol Abuse
|
February 13, 2009
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market
R Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2011
Policy implications of integrating buprenorphine/naloxone treatment and HIV care
Ruth Finkelstein, Julie Netherland, Laurie Sylla, et al.
The American Journal of Drug and Alcohol Abuse
|
June 28, 2008
Case series of buprenorphine injectors in Kuala Lumpur, Malaysia
R Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Journal of Empirical Research on Human Research Ethics : JERHRE
|
November 29, 2017
Reply to Commentary: "Are HIV-Infected Candidates for Participation in Risky Cure-Related Studies Otherwise Healthy?"
Karine Dubé, Laurie Sylla, Lynda Dee
American Journal of Public Health
|
December 15, 2012
A pilot study of the impact of housing first-supported housing for intensive users of medical hospitalization and sobering services
Debra Srebnik, Tara Connor, Laurie Sylla
Psychiatric Services (Washington, D.C.)
|
February 3, 2015
A pilot study of the diabetes prevention program on weight loss for adults at community mental health centers
Debra Srebnik, Lydia A Chwastiak, Joan Russo, et al.
The International Journal on Drug Policy
|
August 11, 2007
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications
R Douglas Bruce, Sergey Dvoryak, Laurie Sylla, et al.
HIV Research & Clinical Practice
|
July 29, 2022
Community HIV clinicians' perceptions about HIV cure-related research in the Northwestern United States
Laurie Sylla, Hursch Patel, Michael Louella, et al.
The Journal of Behavioral Health Services & Research
|
August 13, 2016
Creating a Regional Model to Coordinate and Prioritize Access to Permanent Supportive Housing
Laurie Sylla, René Franzen, Debra Srebnik, et al.
The International Journal on Drug Policy
|
August 11, 2007
Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services
Laurie Sylla, R Douglas Bruce, Adeeba Kamarulzaman, et al.
The American Journal of Drug and Alcohol Abuse
|
February 13, 2009
Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market
R Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
February 15, 2011
Policy implications of integrating buprenorphine/naloxone treatment and HIV care
Ruth Finkelstein, Julie Netherland, Laurie Sylla, et al.
The American Journal of Drug and Alcohol Abuse
|
June 28, 2008
Case series of buprenorphine injectors in Kuala Lumpur, Malaysia
R Douglas Bruce, Sumathi Govindasamy, Laurie Sylla, et al.
Page
of 3